PHK
WVE icon

Point72 Hong Kong’s Wave Life Sciences WVE Stock Holding History

Point72 Hong Kong’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$34.8K Buy
+4,753
New +$38.5K ﹤0.01% 389
2022
Q1 		– Sell
-2,347
Closed -$7K – 2384
2021
Q4 		$7K Sell
2,347
-5,496
-70% -$22.8K ﹤0.01% 1701
2021
Q3 		$38K Buy
7,843
+5,449
+228% +$33K ﹤0.01% 1592
2021
Q2 		$16K Buy
2,394
+1,877
+363% +$12.3K ﹤0.01% 1671
2021
Q1 		$3K Buy
+517
New +$4.97K ﹤0.01% 1695
2020
Q4 		– Sell
-3,481
Closed -$30K – 2084
2020
Q3 		$30K Buy
+3,481
New +$38.2K ﹤0.01% 786
2020
Q1 		– Sell
-582
Closed -$5K – 1405
2019
Q4 		$5K Buy
+582
New +$14.3K ﹤0.01% 1042
2019
Q2 		– Sell
-1,173
Closed -$46K – 1440
2019
Q1 		$46K Buy
1,173
+1,137
+3,158% +$46.1K 0.02% 551
2018
Q4 		$2K Sell
36
-284
-89% -$12.6K ﹤0.01% 758
2018
Q3 		$16K Buy
320
+284
+789% +$12.8K 0.01% 617
2018
Q2 		$1K Sell
36
-260
-88% -$11.2K ﹤0.01% 842
2018
Q1 		$12K Buy
+296
New +$12.4K 0.01% 683

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Point72 Hong Kong's WVE Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in Wave Life Sciences (WVE) in Q3 2025: 4,753 shares worth $34.8K. The stake represents ﹤0.01% of the portfolio and ranks #389 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in WVE as recently as Q4 2021.

Point72 Hong Kong first reported a position in WVE in Q1 2018 and has held it in 12 quarters since. The position peaked at $46K in Q1 2019. 189 funds tracked by Wall St. Rank hold WVE as of Q3 2025.

  • Point72 Hong Kong held 4,753 shares of Wave Life Sciences worth $34.8K as of Q3 2025.
  • Wave Life Sciences was a new Point72 Hong Kong position in Q3 2025.
  • Wave Life Sciences made up ﹤0.01% of Point72 Hong Kong's portfolio in Q3 2025, its #389 holding.
  • Point72 Hong Kong first reported a position in Wave Life Sciences in Q1 2018 and has held it in 12 quarters since.
  • Point72 Hong Kong's Wave Life Sciences position peaked at $46K in Q1 2019.
  • 189 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.